Cleared Traditional

K110594 - GF-210R MULTI-GAS MODULE FOR NOHON KOHDEN BEDSIDE MONITORS

K110594 is an FDA 510(k) clearance for GF-210R MULTI-GAS MODULE FOR NOHON KOHD..., manufactured by Nihon Kohden Corp.. The device is a Class 2 Anesthesiology device with product code CCK cleared through the Traditional 510(k) pathway after a 240-day FDA review.

K110594 · Nihon Kohden Corp. · Anesthesiology device
Download Printable Device Report (PDF) Official FDA 510(k) Summary (PDF)
Optimized for regulatory review, auditing and printing
Oct 2011
Decision
240d
Days
Class 2
Risk

K110594 is an FDA 510(k) clearance for the GF-210R MULTI-GAS MODULE FOR NOHON KOHDEN BEDSIDE MONITORS. Classified as Analyzer, Gas, Carbon-dioxide, Gaseous-phase (product code CCK), Class II - Special Controls.

Submitted by Nihon Kohden Corp. (Foothill, US). The FDA issued a Cleared decision on October 28, 2011 after a review of 240 days - an extended review cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1400 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Anesthesiology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K110594

510(k) Number K110594 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 02, 2011
Decision Date October 28, 2011
Days to Decision 240 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
100d slower than avg
Panel avg: 140d · This submission: 240d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CCK Device Classification - Class 2, Special Controls

Product Code CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase

All 266
Devices cleared under the same product code (CCK) and FDA review panel - the closest regulatory comparables to K110594.
CAPNODURA COMBI & CAPNODURA PEDI CO2 DETECTOR
K112840 · Seebreath AB · Jul 2012
CAPNOGRAPHY PAD (92516)
K121017 · Spacelabs Healthcare · Jul 2012
END TIDAL CO2 NASAL CANNULA
K120518 · Care Fusion · May 2012
ISA CO2, ISA AX+, ISA OR+
K103604 · Phasein AB · Apr 2011
CAPNOSTREAM20 WITH MICROMEDICO2 MODULE
K094012 · Oridion Capnography, Inc. · May 2010
INFINITY MCABLE - MAINSTREAM CO2
K100941 · Draeger Medical AG & Co. KG · Apr 2010